id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-328068-qoz85x3r	Alanio, Alexandre	The presence of Pneumocystis jirovecii in critically ill patients with COVID-19	2020-11-04		.txt	text/plain	1383	87	46	title: The presence of Pneumocystis jirovecii in critically ill patients with COVID-19 3 Since pneumocystosis is usually reported in patients with T-cell immunodepression, 4 less attention has been paid to Pneumocystis jirovecii in non-immunocompromised ICU patients although it accounts for 7% of the co-infections reported in those admitted with Influenza. jirovecii acid nucleic detection in respiratory specimens sampled to identify co-infections in COVID-19 patients in the ICU. All consecutive patients admitted to the ICU between 2020/03/15 and 2020/05/01 with a positive SARS-CoV-2 PCR (Cobas ® SARS-CoV-2 Test, Roche, France) and ≥1 respiratory sample (bronchoalveolar lavage (BAL), tracheal aspirate, sputum) sent to the mycology department. jirovecii RTqPCR-negative patients, higher B-D-glucan concentrations (450 and 500pg/ml) lead to the diagnosis of pulmonary aspergillosis, another fungal infection of risk in COVID-19 patients. jirovecii-positive pulmonary samples is observed in critically ill COVID-19 patients. Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	./cache/cord-328068-qoz85x3r.txt	./txt/cord-328068-qoz85x3r.txt